Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 2
1988 2
1989 2
1990 2
1992 2
1993 1
1995 1
1996 2
1997 6
1998 2
1999 3
2000 3
2001 3
2003 3
2004 5
2005 4
2006 2
2007 4
2008 2
2009 1
2010 3
2011 4
2012 4
2013 2
2014 4
2015 6
2016 6
2017 9
2018 4
2019 3
2020 7
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Among authors: keler t. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Antibody-targeted vaccines.
Keler T, He L, Ramakrishna V, Champion B. Keler T, et al. Oncogene. 2007 May 28;26(25):3758-67. doi: 10.1038/sj.onc.1210375. Oncogene. 2007. PMID: 17530028 Review.
Mannose receptor-targeted vaccines.
Keler T, Ramakrishna V, Fanger MW. Keler T, et al. Expert Opin Biol Ther. 2004 Dec;4(12):1953-62. doi: 10.1517/14712598.4.12.1953. Expert Opin Biol Ther. 2004. PMID: 15571457 Review.
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
Vitale LA, Thomas LJ, He LZ, O'Neill T, Widger J, Crocker A, Sundarapandiyan K, Storey JR, Forsberg EM, Weidlick J, Baronas AR, Gergel LE, Boyer JM, Sisson C, Goldstein J, Marsh HC Jr, Keler T. Vitale LA, et al. Among authors: keler t. Cancer Immunol Immunother. 2019 Feb;68(2):233-245. doi: 10.1007/s00262-018-2267-0. Epub 2018 Oct 31. Cancer Immunol Immunother. 2019. PMID: 30382327
Conventional Dendritic Cells Impair Recovery after Myocardial Infarction.
Lee JS, Jeong SJ, Kim S, Chalifour L, Yun TJ, Miah MA, Li B, Majdoubi A, Sabourin A, Keler T, Guimond JV, Haddad E, Choi EY, Epelman S, Choi JH, Thibodeau J, Oh GT, Cheong C. Lee JS, et al. Among authors: keler t. J Immunol. 2018 Sep 15;201(6):1784-1798. doi: 10.4049/jimmunol.1800322. Epub 2018 Aug 10. J Immunol. 2018. PMID: 30097529 Free article.
109 results